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WHAT'S KNOWN ON THIS SUBJECT: Participating in a trial may affect processes of care by participating physicians; however, no study has assessed whether it affects processes of care for nonenrolled patients.
WHAT THIS STUDY ADDS: Participation in a trial may affect processes of care for nonenrolled patients, even when care providers participating in or familiar with the trial protocol are unaware that data on nonenrolled patients are being collected for a study. weeks' gestational age (GA) were randomized in the delivery room (DR) to endotracheal intubation or nasal continuous positive airway pressure. We hypothesized that DR intubation could change in nonenrolled patients at PMH and that the change would be larger than in comparable centers not participating in the trial.
METHODS:
The PMH Cohort included eligible but nonenrolled neonates of 24 0/7 to 27 6/7 weeks (primary) and noneligible neonates of 28 to 34 6/7 weeks (confirmatory). A subset (24 0/7 -29 6/7 weeks) of that cohort was compared with a contemporaneous cohort born in centers participating in the Vermont Oxford Network (VON). We used a Poisson regression model to obtain adjusted relative risks (RRs) of DR intubation (during/after SUPPORT versus before SUPPORT) for PMH and for VON along with the ratio of these RRs.
RESULTS:
In the PMH cohort (n = 3527), the proportion of DR intubation decreased during/after SUPPORT in the lower GA group (adjusted RR 0.76, 95% confidence interval [CI] 0.59-0.96) and the upper GA group (adjusted RR 0.57, 95% CI 0.46-0.70). Compared with the RR for DR intubation in VON, the RR at PMH was smaller in the lower (ratio of RR 0.76, 95% CI 0.65-0.87) and the upper GA group (ratio of RR 0.52, 95% CI 0.39-0.68).
CONCLUSIONS: A center' s participation in an unblinded randomized trial may affect process of care of nonenrolled patients. Pediatrics 2013;132:e960-e970 Dr LeVan conceptualized and designed the study, merged data from all Parkland Memorial Hospital (PMH) databases, participated in the interpretation of the data, drafted the first version of the manuscript, and critically reviewed the revisions; Drs Wyckoff, Heyne, Sanchez, Chalak, and Jaleel conceptualized and designed the study, participated in the interpretation of the data, and critically reviewed the manuscript; Dr Ahn conducted statistical analyses for the PMH cohort, participated in the interpretation of the data, and critically reviewed the manuscript; Ms Burchfield and Ms Christie collected and entered data into the databases and extracted the data for the PMH cohort, participated in the interpretation of the data, and critically reviewed the manuscript; Dr Soll conceptualized and designed the comparison between the 2 cohorts, participated in the interpretation of the data, and critically reviewed the manuscript; Dr Badger conceptualized, designed, and conducted the statistical analyses for the comparison between the 2 cohorts, participated in the interpretation of the data, and critically reviewed the manuscript; Dr Brion conceptualized and designed the study, conducted statistical analyses for the PMH cohort, participated in the interpretation of the data, and critically reviewed and revised the manuscript; and all authors approved the final manuscript as submitted.
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Outcomes in control patients enrolled in randomized controlled trials (RCTs) may be better than contemporaneous, eligible but nonenrolled patients. 1,2 Differences in outcomes between enrolled and nonenrolled patients could be a trial effect or a spurious association due to bias. 1 Andersen et al showed that conducting a seeding trial (companydriven trial to entice doctors to prescribe a new drug being marketed by the company) changed some processes of care among participating physicians compared with nonparticipating physicians; however, processes of care for nonenrolled patients were not assessed. 3, 4 The objective of the current study was to evaluate whether a process of care of contemporaneous nonenrolled patients canchangeduringandafterrecruitment to an unblinded randomized trial, when care providers participating in or familiar with the trial protocol are unaware that data on nonenrolled patients are being collected for a study. We hypothesized (1) that participation of Parkland Memorial Hospital (PMH) in the Surfactant, Positive Pressure, and Oxygenation Randomized Trial (SUPPORT), an unblinded RCT comparing processes of care, could be associated with a reduction in the proportion of delivery room (DR) intubation in nonenrolled patients, and (2) that the local practice change would be larger than in comparable centers not participating in SUPPORT.
METHODS

Setting
The Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network (NRN) SUPPORT trial was a multicenter randomized 2 3 2 factorial trial in which preterm neonates of 24 0/7 to 27 6/7 weeks' gestational age (GA) were randomized at birth to 2 interventions: (1) continuous positive airway pressure (CPAP) initiated in the DR and subsequent use of a protocol-driven limited ventilation strategy or DR intubation with surfactant administration, and (2) oxygen saturation targets of 85% to 89% or 91% to 95%. 5, 6 The first intervention (CPAP versus DR intubation/surfactant) was unblinded, and its primary outcome was death or bronchopulmonary dysplasia at 36 weeks' postmenstrual age. 5 9 and neonates who received comfort care in the DR (death without endotracheal intubation), or had severe congenital anomalies. This GA range was selected because infants in this GA range are included in the 501 to 1500 g BW range of VON. PMH was not a member of VON during the study period.
Comparisons of Interest
PMH Cohort
The primary analysis was the adjusted relative risk (RR) of DR intubation ARTICLE during/after SUPPORT versus before SUPPORT in the lower GA group. The adjusted RR in the upper GA group was confirmatory and used as a positive control.
Univariate analyses in each GA group evaluated DR treatment (endotracheal intubation, positive pressure ventilation, CPAP), intubation (within the first 4 hours after admission to the NICU or during the first 24 hours of age), surfactant administration, pneumothorax, mortality to discharge from the hospital, chronic lung disease (chronic changes on chest radiograph and supplemental oxygen requirement for at least 28 days), duration of mechanical ventilation, patent ductus arteriosus, necrotizing enterocolitis (stage II or greater, modified Bell classification), 10 severe intraventricular hemorrhage (Papile grade III or IV), 11 periventricular leukomalacia, and severe retinopathy of prematurity (grade 3 or higher, international classification). 12 
Comparison With VON
The primary analysis was the comparison of RR (adjusted for baseline variables) of DR intubation (during/after SUPPORT versus before SUPPORT) in the subset of the PMH cohort in the lower GA group with the RR of DR intubation in the contemporaneous VON cohort.
The secondary analyses were (1) the adjusted ratio of RRs for DR intubation in the upper GA group and (2) the adjusted ratio of RRs for any invasive (endotracheal tube or tracheostomy) ventilation.
Statistical Analysis: PMH Cohort
Multivariate Analyses
In each GA group, the adjusted RRs for DR intubation during/after SUPPORT versus before SUPPORTwere calculated using robust Poisson regression in a generalized estimating equation model adjusted for covariates that met the P , .05 criterion (backward selection).
Candidate variables selected for modeling were characteristics preceding the decision of DR intubation and shown previously to associate with DR intubation. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] To avoid collinearity with GA, BW was converted to BW z-score. 28 The adjusted risk difference (RD) and number needed to treat (NNT) were obtained from the adjusted RR and the proportion of DR intubation before SUPPORT. The Altman interaction test 29 was used to determine if the adjusted RRs for DR intubation were different between GA groups.
Univariate Analyses
Univariate analyses were performed by using x 2 tests or Fisher' s exact tests for categorical variables, and Student' s t tests or analyses of variance followed by Tukey test, or Kruskal-Wallis test followed by Mann-Whitney test for continuous variables. We analyzed temporal patterns of DR intubation to determine how soon after initiating SUPPORT the proportion of DR intubation changed from baseline; we selected blocks of 15 to 16 months to limit fluctuation due to sample size.
Statistical analyses were performed by using SPSS version 19 (IBM SPSS Statistics, IBM Corporation, Armonk, NY) and SAS version 9.2 (SAS Institute, Cary, NC). Statistical significance (2-tailed) was determined based on P , .05, except for multiple pairwise nonparametric comparisons, for which we used the Bonferroni adjustment.
The time interval for data abstraction was set to ascertain a sufficient number of registered patients in the PMH cohort to detect changes in DR intubation in the lower GA subgroup using multivariate analysis. Given the ascertainment of data on 200 DR intubations, the analysis set was sufficient to conduct a multivariate analysis with up to 20 independent covariates tested as main effects, with a 2-sided a of 0.05. The duration of the study was set to recruit enough patients to detect changes in DR intubation in the lower GA group by univariate analysis. The effect size was selected as a 33% RR reduction in DR intubation, a conservative estimate compared with the 47% RR reduction in DR intubation in a center in which routine DR bubble CPAP was prospectively introduced in 2000. 21 A sample of 97 patients before SUPPORT and during/ after SUPPORT yielded 80% power to detect a reduction in DR intubation from 60% to 40% with a 2-sided a of 0.05.
Comparison With VON
A Poisson regression model with robust variance was used for each GA group to obtain adjusted RRs (during/after SUPPORT versus before SUPPORT) for PMH and VON along with the ratio of their RRs. 30 Covariates in the model were infants' GA, gender, BW, z-score, and antenatal steroids. Location (PMH and VON) and epoch (before and during/after SUPPORT) were represented by a 4-level categorical variable in the model, with the appropriate linear contrasts constructed to obtain estimates of RRs and their ratio.
RESULTS
PMH Cohort
At PMH, a total of 3821 individual patient database records were reviewed, of which 3533 were eligible and 3527 (99.8%) had records in the 3 PMH databases (Fig 1) . The analysis cohort comprised 3527 records. In the lower GA group, the percentage of multiple births was lower after SUPPORT (Table 1 ). In the upper GA group, exposure to antenatal steroids was more frequent after SUPPORT, maternal diabetes was more frequent during SUPPORT, and BW was greater during/after SUPPORT; other differences were clinically insignificant (Table 2) .
During SUPPORT, patients in the lower GA group included in the current study had a greater GA than contemporaneous patients enrolled in SUPPORT (excluded from the current study), were less likely to have been exposed to antenatal steroids, and were more likely to receive positive pressure ventilation in the DR (Appendix).
Multivariate Analysis
Among 3527 neonates, 649 (18%) were intubated in the DR. The proportion of DR intubation significantly decreased during/after SUPPORT versus before SUPPORT, in the lower GA group (adjusted RR 0.76, 95% confidence interval [CI] 0.59-0.96, P = .02) and in the upper GA group (adjusted RR 0.57, 95% CI 0.46-0.70, P , .001) ( Tables 3 and 4 ). In the lower GA group, the proportion of DR intubation decreased from 85% before SUPPORT to 61% during/after SUPPORT (Table 5 ) (adjusted RD 0.21, 95% CI 0.03-0.34; NNT 5, 95% CI 3-33). In the upper GA group, the proportion decreased from 19% to 10% (Table 6 ) (adjusted RD 0.08, 95% CI 0.06-0.10; NNT 12, 95% CI 10-18). The decrease in DR intubation was not significantly different in the upper GA group compared with the lower GA group (adjusted ratio of RR 0.75, 95% CI 0.54-1.03).
Univariate Analyses
In the lower GA group, administration of DR positive pressure ventilation decreased during/after SUPPORT (P = .01) and that of CPAP increased (P , .001) ( Table 5 ). Not surprisingly, the proportion of intubation in the NICU within 4 hours after admission increased over time (P = .03); however, intubation within 24 hours of life decreased during/after SUPPORT (P = .002). The proportion of surfactant administration decreased during SUPPORT (P , .001). The proportion of pneumothoraces increased after SUPPORT (P = .03). Most pneumothoraces occurred in neonates who were intubated in the DR.
In the upper GA group, administration of DR positive pressure ventilation decreased during/after SUPPORT (P = .002) ( Table 6 ). The proportion of intubation within 24 hours of life decreased during/after SUPPORT (P , Most of the other outcomes except retinopathy of prematurity did not change during or after SUPPORT. The percentage of DR intubation did not change during baseline in either GA group (Fig 2) . In the lower GA group, the proportion of DR intubation decreased within 15 months of SUPPORT, whereas in the upper GA group, it did not significantly change until later. In the upper GA group, the proportion of DR intubation decreased from before SUPPORT to during/after SUPPORT both at PMH and in VON. The decrease was greater at PMH than in VON (adjusted ratio of RR 0.52, 95% CI 0.39-0.68). The proportion of overall ventilator support did not change significantly from before to during/after SUPPORT in the PMH cohort but changed significantly in VON. The change over time was not significantly different between PMH and VON.
DISCUSSION
In the current study, a change in care process (proportion of DR intubation) was observed in eligible but nonenrolled patients and in noneligible more mature patients soon after SUPPORT initiation and persisted through 16 months of posttrial evaluation. This change in practice at PMH was much larger than in other comparable centers that did not participate in any trial involving random allocation to DR .001 Pneumothorax, n (%) 11 (7) 13 (10) 14 (18)* .03 Death before discharge, n (%)
43 (27) 34 (26) 18 (24) .91 Chronic lung disease, n (%)
83 (52) 14 (9) 10 (8) 5 (7) .91 Intraventricular hemorrhage, grade 3 or 4, n (%)
25 (16) 20 (15) 18 (24) .25
Periventricular leukomalacia, n (%) 9 (6) 7 (5) 5 (7) .92 Retinopathy of prematurity, stage $3, n (%)
30 (19) 12 (9) 14 (18) .04
P values in the last column on the right are based on x 2 analysis (Fisher' s exact tests where needed) or Kruskal-Wallis tests.
Subsequent pairwise comparisons were performed by using x 2 tests, Fisher' s exact tests, or Tukey tests, with significance determined by using P , .025, and P values indicated as * P , .025, or ** P , .001. Pairwise comparisons were performed between during SUPPORT and before SUPPORT and between after SUPPORT and before SUPPORT. a Complete data were available for patients. b Two patients, initially intubated in the DR, were intubated again within 4 h after admission in the NICU after a trial on CPAP. c Kruskal-Wallis tests. During SUPPORT, n = 1657
After SUPPORT, n = 549 P Value Intubation in the DR, n (%) 177 (19) 162 (10)** 47 (9)** ,.001 Positive pressure ventilation in the DR, n (%) 332 (36) 513 (31)* 150 (28)** .002 CPAP in the DR, n (%) 314 (34) 588 (36) 194 (36) .74 Intubation in the NICU within the first 4 h after admission to the unit, n (%)
43 (5) 82 (5) 28 (5) .84
Intubation during the first 24 h of life, n (%) 220 (23) 242 (15)** 75 (14)** ,.001 Surfactant, n (%)
105 (11) 131 (8)* 50 (9) .01 Pneumothorax, n (%)
29 (3) 40 (2) 12 (2) .51 Death before discharge, n (%)
17 (2) 19 (1) 8 (2) .41 Chronic lung disease, n (%)
31 (3) 40 (2) 16 (3) .44 Total no. days intubated (endotracheal tube or tracheostomy) (n = 694); median (quartiles)
Patent ductus arteriosus, n (%) 68 (7) 106 (6) 23 (4) .07 Necrotizing enterocolitis, stage $2, n (%)
17 (2) 23 (1) 12 (2) . Subsequent pairwise comparisons were performed by using x 2 tests, Fisher' s exact tests, or Tukey tests, with significance determined by using P , .025, and P values indicated as * P , .025, or ** P , .001. Pairwise comparisons were performed between during SUPPORT and before SUPPORT and between after SUPPORT and before SUPPORT. a 95% of data were available; we used the total number available as denominator. b Kruskal-Wallis tests.
ARTICLE
centers not participating in DR trials) with a similar baseline proportion of DR intubation. Secular trends are unlikely to explain the primary results because DR intubation at PMH decreased much more than in other comparable centers. It is unlikely that the current study affected the proportion of DR intubation because when the first data were obtained and presented at a national meeting, the change in practice had already taken place. We did not observe a regression to the mean but instead a sustained reduction in DR intubation at PMH during/after SUPPORT. A differential Hawthorne effect was ruled out because providers were not aware of an observational study of eligible, nonenrolled patients during SUPPORT. 7, 8 This study was limited to a single institution rather than all NRN centers participating in SUPPORT because the generic database of the NRN includes only the most immature infants; patients in the upper GA group were important in this study as positive controls who were not eligible for SUPPORT and thus not subjected to selection bias. Selection bias at PMH in the lower GA group during SUPPORT is unlikely to explain the observed decrease in DR intubation in nonenrolled patients, because respiratory distress is associated with lower exposure to antenatal steroids, 35 and more frequent DR positive pressure ventilation (Appendix) would be expected to increase, rather than decrease, DR intubation. The lower percentage of antenatal steroids among nonenrolled patients could have resulted because of many reasons, including not enough time before delivery. 7 Rich and colleagues' study showed that a significantly larger proportion of eligible infants whose mothers were not approached for consent to SUPPORT had no prenatal steroid exposure. 7 The frequency of antenatal corticosteroid administration at PMH is low because preeclampsia and diabetes are considered contraindications. 36 Multivariate analyses showed that the RR of DR intubation decreased at PMH and decreased more at PMH than in VON, even taking into account antenatal corticosteroid administration. We were unable to analyze bronchopulmonary dysplasia, or other elements of care process examined in SUPPORT (ie, targeted ventilation strategy and oxygen saturation), which were not included in the PMH databases. In addition, target oxygen saturation values of 88% to 94%, a PMH NICU policy since May 2002, 37 
FIGURE 2
Analysis of temporal patterns in DR intubation rates by GA group at PMH. This analysis was performed using consecutive 15-to 16-month blocks. A, Lower GA group (24 0/7 -27 6/7 weeks' GA infants): The percentages of DR intubation were not significantly different between blocks before SUPPORT (P = .37); therefore, the overall percentage before SUPPORT was used as baseline for further comparisons. The percentage of DR intubations decreased after starting recruitment into the SUPPORT (P , .001). This change already occurred within the first 15 months of recruitment into SUPPORT. *Indicates significant (with Bonferroni adjustment, P , .0125) pairwise difference from baseline before starting the SUPPORT. B, Upper GA group (28 0/7 -34 6/7 weeks' GA infants). The percentage of DR intubations was not significantly different between the 2 blocks before SUPPORT (P = .10); therefore, the overall percentage before SUPPORT was used as baseline for further comparisons. The percentage of DR intubations decreased after starting recruitment into SUPPORT (P , .001); however, this change started to reach significance only after 15 months of recruitment into SUPPORT. *Indicates significant (with Bonferroni adjustment, P , .0125) pairwise difference from baseline before starting SUPPORT.
was used for nonenrolled patients. Because the study used databases, it was not possible to perform a propensity match, or a cluster analysis of DR team members or individual providers and to obtain their rationale for deciding whether to intubate the trachea. It is possible that the change in DR intubation was related to increased availability of T-piece devices for DR resuscitation, or to training and experience with these devices and DR CPAP.
CONCLUSIONS
A change in process of care was observed in nonenrolled patients during/ after recruitment to an unblinded RCT, in the absence of changes in standard care, initiation of a protocol, or previously described trial effect. This suggests that care for patients who are not enrolled in RCTs should routinely be monitored and audited to identify changes in practice that may either be beneficial or detrimental without the evidence from a completed trial. Further studies are needed to investigate the determinants of changes in individual decisions about care process (eg, observations of short-term outcomes versus experience with novel 
